Stop Taking Nan Bao!

HealthPharmacy
Last updated on
Avatar photo
By Bryan Tan Van Hong

Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

If you are one of those who consumes ‘Nan Bao’ capsules, be aware that the Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has released a statement that all sellers and distributors of this traditional supplement to stop all sales and distribution as it is against the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984.

These capsules are found to contain sildenafil and tadalafil, both which are ingredients used medically to treat erectile dysfunction. These medication can only be obtained via a prescription from a doctor. Supplements containing these are not allowed to be classified as traditional.

“The use of sildenafil and tadalafil without a doctor’s advice can cause serious adverse effects such as impairment of vision and hearing, low blood pressure, and effects to the cardiovascular systems such as stroke and heart attack.” The misuse of these medication can prove to be dangerous especially those who consume medication containing nitrates.

If you had tried taking or is currently taking “Nan Bao” supplements, visit your nearest doctor or pharmacist if you experience any discomfort.

Related

Nope, D614G is not the latest breed of durians in town. We hate to burst your bubble, but it is a mutation on the original COVID-19 virus. Simply put, SARS-CoV-2 got an upgrade, for better or for worse. Source: Giphy The recent announcement on 16th August by DG Datuk Dr Noor Hisham that the D614G-type...

Many of you might have read posts or articles about the issues faced by provisionally registered pharmacists (PRP) securing a place in the government sector after their 1-year training. This came about after the posting results of the first batch of contract Fully Registered Pharmacists (FRPs) in the public sector was released. Many have expressed…

At the Malaysian Society of Hypertension’s (MSH) 15th Annual Scientific Meeting, Professor Abdul Rashid Abdul Rahman, the Chairman Working Group on 5th Malaysian Hypertension Clinical Practice Guidelines (CPG) 2018 said that many updates can be expected from the new CPG. One of these new recommendations is the preference for validated electronic blood pressure (BP) sets over mercury sphygmomanometers....

Remdesivir: Yay or Nay?

Last updated on
Since our last article on Remdesivir, much has been discovered about its potential clinical application via several high-profile clinical trials. On 15th October 2020, we first heard of less-than-promising results from the WHO SOLIDARITY trial that Remdesivir has “little to no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation, and duration...

Stable Coronary Artery Disease (2nd Edition)

Last updated on
The previous clinical practice guidelines for the management of stable angina were issued in 2010. Since then, there have been advances in both diagnostic and therapeutic strategies in the management of this progressive disease. Therefore, it is timely for the publication of this CPG, with a title that is now evolved from stable angina to...

Community Pharmacy Logo

Last updated on

This logo was decided recently from a logo competition carried out by the Pharmaceutical Services Division of the Ministry of Health, in collaboration with MPS.  Through a circular from the Pharmacy Enforcement Division of the Ministry of Health dated 30th January it is compulsory to display this logo at all community pharmacy premise. For existing…

Others

UPDATED (as of 19th Nov 2020) : Malaysia has decided to pay RM94 million upfront and share guarantee payments upon signing the COVAX facility agreement. This is part of the RM3 billion allocated in Budget 2021 to cover COVID-19 vaccine supply access and development. The Malaysian government has also signed another agreement with the Chinese...
[UPDATE] As of 8/12/2020 The Light at the End of the Tunnel On 8 December, the United Kingdom has been the very first nation to begin vaccinating its citizens. 90 year-old Margaret Keenan was the first Briton to receive the Pfizer/BioNTech vaccine. The UK has also placed an order for the Moderna vaccines for a...

WHO to look into drug pricing?

Last updated on

Our health ministry has urged the World Health Organisation (WHO) to look into drug pricing by major drug companies. This came about amidst the pressure on the ministry to utilise Compulsory Licensing (CL)* to gain access to generic versions of a Hepatitis C medication. “I hope the international community could look at how pharmaceutical companies…

Mandatory Immunisation Proposal to Be Discussed

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   On May 8, the proposal on mandatory immunisation will be tabled with the Ministry of Health’s steering committee. This is to be done before it is presented to the cabinet. Opinions from various…

We are very honor to be mentioned byInternational Pharmaceutical Federation (FIP)Education report as one of the bodies along with#MPS and Malaysian Pharmacy Students’ Association (MyPSA) in training leadership for pharmacists. We are grateful to all authors for this comprehensive report! We will do our level best in nurturing the next generation of pharmacy leaders. The full report can…

Sometime in late February, we had the privilege to attend a talk conducted by the co-founder of the Tobacco Free Generation International (TFGI), Dr Koong. Other than ourselves, respected representatives from the Malaysian Women's Action for Tobacco Control and Health (MyWATCH) group such as Dr Samsinar Hussain, Dr Zarihah & Dr Lydia were also present...